Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol.

Price JT, Mollan KR, Fuseini NM, Freeman BL, Mulenga HB, Corbett AH, Vwalika B, Stringer JSA.

Pilot Feasibility Stud. 2017 Jul 18;4:21. doi: 10.1186/s40814-017-0170-7. eCollection 2018. Erratum in: Pilot Feasibility Stud. 2017 Oct 24;3:48.

2.

Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial.

Siou K, Walmsley SL, Murphy KE, Raboud J, Loutfy M, Yudin MH, Silverman M, Ladhani NN, Serghides L.

Pilot Feasibility Stud. 2016 Aug 12;2:49. eCollection 2016. Erratum in: Pilot Feasibility Stud. 2017 Apr 28;3:21.

3.

Perinatal Antiretroviral Exposure and Prevented Mother-to-child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.

Little KM, Taylor AW, Borkowf CB, Mendoza MC, Lampe MA, Weidle PJ, Nesheim SR.

Pediatr Infect Dis J. 2017 Jan;36(1):66-71.

PMID:
27749662
4.

Multiple Overimputation to Address Missing Data and Measurement Error: Application to HIV Treatment During Pregnancy and Pregnancy Outcomes.

Bengtson AM, Westreich D, Musonda P, Pettifor A, Chibwesha C, Chi BH, Vwalika B, Pence BW, Stringer JS, Miller WC.

Epidemiology. 2016 Sep;27(5):642-50. doi: 10.1097/EDE.0000000000000494.

5.
6.

Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study.

Caniglia EC, Patel K, Huo Y, Williams PL, Kapetanovic S, Rich KC, Sirois PA, Jacobson DL, Hernandez-Diaz S, Hernán MA, Seage GR 3rd; Pediatric HIVAIDS Cohort Study.

AIDS. 2016 May 15;30(8):1267-78. doi: 10.1097/QAD.0000000000001052.

7.

Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.

Money DM, Wagner EC, Maan EJ, Chaworth-Musters T, Gadawski I, van Schalkwyk JE, Forbes JC, Burdge DR, Albert AY, Lohn Z, Côté HC; Oak Tree Clinic Research Group.

PLoS One. 2015 Aug 6;10(8):e0135041. doi: 10.1371/journal.pone.0135041. eCollection 2015.

8.

Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?

Kakkar F, Boucoiran I, Lamarre V, Ducruet T, Amre D, Soudeyns H, Lapointe N, Boucher M.

J Int AIDS Soc. 2015 Jun 5;18:19933. doi: 10.7448/IAS.18.1.19933. eCollection 2015.

9.

Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population.

Phiri K, Williams PL, Dugan KB, Fischer MA, Cooper WO, Seage GR 3rd, Hernandez-Diaz S.

Pediatr Infect Dis J. 2015 Jul;34(7):e169-75. doi: 10.1097/INF.0000000000000712.

10.

Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.

Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):128-35. doi: 10.1097/QAI.0000000000000281.

11.

Ten years of experience in the prevention of mother-to-child human immunodeficiency virus transmission in a university teaching hospital.

Park JW, Yang TW, Kim YK, Choi BM, Kim HJ, Park DW.

Korean J Pediatr. 2014 Mar;57(3):117-24. doi: 10.3345/kjp.2014.57.3.117. Epub 2014 Mar 31.

12.

Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants.

Slyker JA, Patterson J, Ambler G, Richardson BA, Maleche-Obimbo E, Bosire R, Mbori-Ngacha D, Farquhar C, John-Stewart G.

BMC Pregnancy Childbirth. 2014 Jan 8;14:7. doi: 10.1186/1471-2393-14-7.

13.

Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Read JS, Huo Y, Patel K, Mitchell M, Scott GB.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):92-102. doi: 10.1093/jpids/pis036. Epub 2012 May 3.

14.

Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.

Taylor AW, Mosimaneotsile B, Mathebula U, Mathoma A, Moathlodi R, Theebetsile I, Samandari T.

Infect Dis Obstet Gynecol. 2013;2013:195637. doi: 10.1155/2013/195637. Epub 2013 Mar 7.

15.

Growth and body composition of uninfected children exposed to human immunodeficiency virus: comparison with a contemporary cohort and United States National Standards.

Neri D, Somarriba GA, Schaefer NN, Chaparro AI, Scott GB, Lopez Mitnik G, Ludwig DA, Miller TL.

J Pediatr. 2013 Jul;163(1):249-54.e1-2. doi: 10.1016/j.jpeds.2012.12.034. Epub 2013 Jan 26.

16.

Combination antiretroviral use and preterm birth.

Watts DH, Williams PL, Kacanek D, Griner R, Rich K, Hazra R, Mofenson LM, Mendez HA; Pediatric HIV/AIDS Cohort Study.

J Infect Dis. 2013 Feb 15;207(4):612-21. doi: 10.1093/infdis/jis728. Epub 2012 Nov 29.

17.

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2012 Dec 1;206(11):1695-705. doi: 10.1093/infdis/jis553. Epub 2012 Oct 12.

18.

Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women.

Ezechi OC, David AN, Gab-Okafor CV, Ohwodo H, Oladele DA, Kalejaiye OO, Ezeobi PM, Gbajabiamila TA, Adu RA, Oke B, Musa ZA, Ekama SO, Ilesanmi O, Odubela O, Somefun EO, Herbertson EC, Onwujekwe DI, Ujah IA.

BMC Pregnancy Childbirth. 2012 Sep 9;12:93.

19.

Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy.

Aaron E, Bonacquisti A, Mathew L, Alleyne G, Bamford LP, Culhane JF.

Infect Dis Obstet Gynecol. 2012;2012:135030. doi: 10.1155/2012/135030. Epub 2012 Jun 20.

20.

Mother-to-child transmission of human immunodeficiency virus in aten years period.

Delicio AM, Milanez H, Amaral E, Morais SS, Lajos GJ, e Silva JL, Cecatti JG.

Reprod Health. 2011 Nov 30;8:35. doi: 10.1186/1742-4755-8-35.

Supplemental Content

Support Center